Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

9B98

Crystal structure of the human PAD2 protein bound to small molecule

This is a non-PDB format compatible entry.
Summary for 9B98
Entry DOI10.2210/pdb9b98/pdb
DescriptorProtein-arginine deiminase type-2, ACETATE ION, CALCIUM ION, ... (5 entities in total)
Functional Keywordscomplex, hydrolase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight79793.48
Authors
Byrnes, L.J.,Vajdos, F. (deposition date: 2024-04-01, release date: 2024-10-09, Last modification date: 2024-10-30)
Primary citationByrnes, L.J.,Choi, W.Y.,Balbo, P.,Banker, M.E.,Chang, J.,Chen, S.,Cheng, X.,Cong, Y.,Culp, J.,Di, H.,Griffor, M.,Hall, J.,Meng, X.,Morgan, B.,Mousseau, J.J.,Nicki, J.,O'Connell, T.,Ramsey, S.,Shaginian, A.,Shanker, S.,Trujillo, J.,Wan, J.,Vincent, F.,Wright, S.W.,Vajdos, F.
Discovery, Characterization, and Structure of a Cell Active PAD2 Inhibitor Acting through a Novel Allosteric Mechanism.
Acs Chem.Biol., 19:2186-2197, 2024
Cited by
PubMed Abstract: Peptidyl arginine deiminases (PADs) are important enzymes in many diseases, especially those involving inflammation and autoimmunity. Despite many years of effort, developing isoform-specific inhibitors has been a challenge. We describe herein the discovery of a potent, noncovalent PAD2 inhibitor, with selectivity over PAD3 and PAD4, from a DNA-encoded library. The biochemical and biophysical characterization of this inhibitor and two noninhibitory binders indicated a novel, Ca competitive mechanism of inhibition. This was confirmed via X-ray crystallographic analysis. Finally, we demonstrate that this inhibitor selectively inhibits PAD2 in a cellular context.
PubMed: 39316753
DOI: 10.1021/acschembio.4c00397
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.003 Å)
Structure validation

227111

건을2024-11-06부터공개중

PDB statisticsPDBj update infoContact PDBjnumon